Product Launches: Proliferation of Syphilis Testing Kits Globally to Bolster the Growth of the Market

Published: Jul 2023

During the projected period (2023-2030), it is anticipated that the global syphilis testing market will expand at a CAGR of 6.2%. Syphilis tests is used to diagnose and find bacteria-specific antibodies in a patient's blood. Syphilis can cause a number of issues, including death from illness and infertility in both sexes, ectopic pregnancy, and cervical cancer in females. The World Health Organization (WHO) estimates that 7.1 million adults between the ages of 15 and 49 globally contracted syphilis. Syphilis cases among males who have intercourse with other men are significantly rising in those nations that routinely monitor the disease, including congenital syphilis. The rising prevalence of STD and technological advances are the primary factors propelling the syphilis test market's expansion. The availability of testing equipment, the quick development of diagnostic instruments, and enhanced healthcare facilities are further drivers anticipated to spur market expansion throughout the projection period. The global market for syphilis testing has grown due to rise in diseases like syphilis and other sexually transmitted illnesses. For instance, in April 2023, according to a report from the Centers for Disease Control and Prevention (CDC), Congenital syphilis cases climbed by 32% from 2,148 to more than 2,800, resulting in 220 stillbirths and infant deaths. These cases happen when a baby is born with the condition after the mother transmitted it to her during pregnancy.

Browse the full report description of “Syphilis Testing Market Size, Share & Trends Analysis Report by Type (Primary and Secondary Syphilis, Latent and Tertiary Syphilis), by Location of Testing (Laboratory Testing, Point-of-Care (POC) Testing), and by Technology (Clinical Laboratory Improvement Amendments (CLIA), Enzyme-Linked Immunosorbent Assay (ELISA), Nucleic Acid Amplification Test (NAAT), and Others), by End User (Hospitals, Diagnostic Labs, Home Care), Forecast Period (2023-2030)” at https://www.omrglobal.com/industry-reports/syphilis-testing-market

The increasing adoption of strategic initiatives by numerous industry-important players is another element promoting market expansion. Syphilis testing kits and complementary service portfolios are being developed with an emphasis on technology developments by the key companies in the market. The important market players in the syphilis testing market include Roche Diagnostics, Hologic, Inc., Becton Dickinson & Company, Abbott laboratories, BioMerieux, Astam Dignostic, Cepheid Inc., Affymetrix, Inc., and Diasorin. For Instance, In February 2023 Mylab discovery Solutions, a company based in Pune, is introducing three new rapid kits for the early and quick diagnosis of STIs like the human immunodeficiency virus (HIV), hepatitis C Virus (HCV), and syphilis. According to predictions from the World Health Organization (WHO), there will be 1 million new cases of STIs each day globally, making these infections a serious health threat.

Market Coverage

The market number available for – 2022-2030

Base year- 2022

Forecast period- 2023-2030

Segment Covered- 

o By Type

o By Location of Testing

o By Technology

Regions Covered-

o North America

o Europe

o Asia-Pacific

o Rest of the World

Competitive Landscape- includes Abbott laboratories, Becton Dickinson and company, Bio-Rad laboratories Inc., F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., and others.

Key questions addressed by the report

What is the market growth rate?

Which segment and region dominate the market in the base year?

Which segment and region will project the fastest growth in the market?

Who is the leader in the market?

How are players addressing challenges to sustain growth?

Where is the investment opportunity?

Global Syphilis Testing Market Report Segment

By Type

  • Primary and secondary syphilis
  • Latent and tertiary syphilis

By Location of Testing

  • Laboratory Testing
  • Point-of-Care (POC) testing

By Technology

  • Clinical Laboratory Improvement Amendments (CLIA)
  • Enzyme-Linked Immunosorbent Assay (ELISA)
  • Nucleic Acid Amplification Test (NAAT)
  • Others 

By End-User

  • Hospitals
  • Diagnostic labs
  • Home care

Global Syphilis Testing Market Report Segment by Region

North America

United States

Canada

Europe

UK

Germany

Italy

Spain

France

Rest of Europe 

Asia-Pacific

China

India

Japan

South Korea

Rest of Asia-Pacific 

Rest of the World

Latin America 

Middle East & Africa


To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/syphilis-testing-market